Host immune response to tuberculous meningitis.

Area of Science:

• Pediatric infectious diseases
• Neuroscience
• Immunology

Background:

• Tuberculous meningitis (TBM) is a severe complication of tuberculosis, particularly affecting young children.
• Delayed diagnosis of TBM, often due to a lack of sensitive diagnostic methods, leads to significant morbidity and mortality.
• Understanding the host immune response to Mycobacterium tuberculosis is key for identifying diagnostic and therapeutic biomarkers.

Purpose of the Study:

• To identify disease-specific biomarkers for childhood tuberculous meningitis (TBM).
• To develop a diagnostic prediction model for TBM in children using identified biomarkers.
• To enhance understanding of TBM pathogenesis and potential immunopathological sequelae.

Main Methods:

• Investigated disease-specific biomarkers in a cohort of children aged 3 months-13 years with meningitis symptoms.
• Analyzed cerebrospinal fluid (CSF) and serum from 56 TBM patients and 55 non-TBM patients for 28 soluble mediators.
• Utilized unsupervised hierarchical clustering analysis to identify disease-specific biomarker patterns.

Main Results:

• A disease-specific biomarker pattern for TBM was identified compared to other meningitis types.
• A diagnostic prediction model for childhood TBM was developed using CSF concentrations of interleukin 13, vascular endothelial growth factor, and cathelicidin LL-37.
• The model achieved a sensitivity of 0.52 and a specificity of 0.95.

Conclusions:

• Biosignatures in cerebrospinal fluid hold significant potential for TBM diagnostic applications.
• These findings can improve the understanding of TBM pathogenesis.
• Further research may lead to strategies for preventing TBM-related immunopathological sequelae.